These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28977863)

  • 1. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining.
    Chen WJ; Tang RX; He RQ; Li DY; Liang L; Zeng JH; Hu XH; Ma J; Li SK; Chen G
    Oncotarget; 2017 Sep; 8(37):61282-61304. PubMed ID: 28977863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
    Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W
    Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.
    Sui J; Xu SY; Han J; Yang SR; Li CY; Yin LH; Pu YP; Liang GY
    Oncotarget; 2017 Sep; 8(39):65997-66018. PubMed ID: 29029488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.
    Tang RX; Chen WJ; He RQ; Zeng JH; Liang L; Li SK; Ma J; Luo DZ; Chen G
    Oncotarget; 2017 Aug; 8(31):50761-50773. PubMed ID: 28881601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.
    Yin YZ; Yao SH; Li CG; Ma YS; Kang ZJ; Zhang JJ; Jia CY; Hou LK; Qin SS; Fan X; Zhang H; Yang MD; Zhang DD; Lu GX; Wang HM; Gu LP; Tian LL; Wang PY; Cao PS; Wu W; Cao ZY; Lv ZW; Shi BW; Wu CY; Jiang GX; Fu D; Yu F
    Am J Transl Res; 2021; 13(1):168-182. PubMed ID: 33527016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.
    Shi YX; Wang Y; Li X; Zhang W; Zhou HH; Yin JY; Liu ZQ
    BMC Genomics; 2017 Nov; 18(1):901. PubMed ID: 29169318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of ribosomal protein S6 kinase A6 in lung squamous cell carcinoma: an immunohistochemical and RNA-seq study.
    Fang YY; Ma FC; Gan XL; Luo WQ; He RQ; Xie HM; Li SY; Chen G; Wei DM; Hu XH
    Int J Clin Exp Pathol; 2018; 11(3):1318-1327. PubMed ID: 31938227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and effect of lncRNA BBOX1-AS1 on the proliferation and migration of lung squamous cell carcinoma.
    Zhang Y; Wang X; Cheng XK; Zong YY; He RQ; Chen G; Qin YJ
    Oncol Lett; 2022 Jan; 23(1):17. PubMed ID: 34820016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
    Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
    Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.
    Yang S; Sui J; Liang G
    PeerJ; 2017; 5():e4101. PubMed ID: 29204322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
    Zhang R; Deng Y; Zhang Y; Zhai GQ; He RQ; Hu XH; Wei DM; Feng ZB; Chen G
    Int J Clin Exp Pathol; 2017; 10(10):10650-10665. PubMed ID: 31966409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma.
    Zhang X; Su Y; Fu X; Xiao J; Qin G; Yu M; Li X; Chen G
    J Oncol; 2022; 2022():9273628. PubMed ID: 35069738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification.
    Liu Z; Ru L; Ma Z
    Front Oncol; 2021; 11():637733. PubMed ID: 34178627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review.
    Sasa GBK; Xuan C; Chen M; Jiang Z; Ding X
    Transl Cancer Res; 2021 Dec; 10(12):5406-5429. PubMed ID: 35116387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway.
    Liu B; Guo S; Li GH; Liu Y; Liu XZ; Yue JB; Guo HY
    J Thorac Dis; 2021 Aug; 13(8):4762-4774. PubMed ID: 34527317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.